Many quantities assayed in clinical laboratories demonstrate age-relat
ed changes. Particularly important periods are early life, adolescence
, old age, and after the menopause in females. The changes that occur
until adulthood are well documented. Fewer data are available on elder
ly people even though they consume a large component of healthcare res
ources. In diagnosis, and prior to initiation of drug therapy, when no
previous results are available, reference values must be available to
aid interpretation. Reference intervals generated from elderly people
are sometimes wider than in younger adults. It is suggested that conv
entional adult reference values should be used in general for the very
elderly since, at least in part, the wider intervals are probably due
to inclusion of individuals who are unhealthy in the reference sample
group. Most quantities have marked individuality, and serial values f
or an individual span only a part of the reference interval. Individua
ls can have values which are very unusual for them but still lie withi
n the reference limits; this implies that clinical laboratory tests wi
ll be less than ideal in the detection of latent or early disease. The
average within-subject variation in healthy elderly people and younge
r adults is similar. Therefore, the large database on biological varia
tion can be used, with analytical imprecision, to calculate critical d
ifferences for serial results in an elderly individual which must be e
xceeded before significance can be claimed. These critical differences
are of value in monitoring the effects of drug therapy.